While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...
DexCom, Inc. (NASDAQ:DXCM) is one of the Best Fundamental Stocks to Buy According to Analysts. On January 12, the company ...
Medical Device Network on MSN
JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth
"JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth" was originally created and published by Medical ...
The NIMA Gluten Sensor is 99% accurate at detecting gluten in your food. All it takes is three minutes. At CES 2026, one of ...
The "The Global Sensors Market 2026-2036" report has been added to ResearchAndMarkets.com's offering.The Global Sensors ...
The study compared CGM to regular fingerprick testing on blood glucose readings after consuming commercial or home-made smoothies or a glucose drink as a control. There has been a major increase in ...
In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback